Rigel Pharmaceuticals Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 1.66 M | $71.28 M | -3.52% | 9.23% |
| STATE STREET CORP | 02/13/2026 | 1.09 M | $46.74 M | 96.86% | 6.05% |
| VANGUARD GROUP INC | 01/29/2026 | 1.04 M | $44.48 M | -0.45% | 5.76% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 836.00 K | $35.81 M | 15.47% | 4.63% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 671.88 K | $28.78 M | -8.84% | 3.72% |
| MARSHALL WACE, LLP | 02/13/2026 | 613.60 K | $26.28 M | 2.04% | 3.40% |
| LSV ASSET MANAGEMENT | 02/06/2026 | 544.28 K | $23.31 M | 390.79% | 3.02% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 539.01 K | $23.09 M | 13.66% | 2.99% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 493.60 K | $21.13 M | -28.02% | 2.74% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 431.46 K | $18.48 M | 309.74% | 2.39% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 424.32 K | $18.17 M | 38.44% | 2.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 424.31 K | $18.18 M | 0.14% | 2.35% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 413.66 K | $17.72 M | 122.01% | 2.29% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 300.03 K | $12.85 M | -9.08% | 1.66% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 288.27 K | $12.35 M | -20.14% | 1.60% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/10/2026 | 282.58 K | $12.10 M | -0.64% | 1.57% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 276.81 K | $11.86 M | 32.20% | 1.53% |
| JANE STREET GROUP, LLC | 02/12/2026 | 275.88 K | $11.82 M | -14.29% | 1.53% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 271.23 K | $11.62 M | 23.12% | 1.50% |
| NUVEEN, LLC | 02/12/2026 | 258.89 K | $11.09 M | 93.98% | 1.44% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 254.49 K | $10.90 M | 100.00% | 1.41% |
| CM MANAGEMENT, LLC | 02/02/2026 | 225.00 K | $9.64 M | 0.00% | 1.25% |
| GLOBEFLEX CAPITAL L P | 02/11/2026 | 217.84 K | $9.33 M | 0.10% | 1.21% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 197.15 K | $8.44 M | 17.97% | 1.09% |
| CITADEL ADVISORS LLC | 02/17/2026 | 185.42 K | $7.94 M | 114.45% | 1.03% |
| MORGAN STANLEY | 02/13/2026 | 166.49 K | $7.13 M | 13.83% | 0.92% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 148.64 K | $6.37 M | -17.34% | 0.82% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 135.43 K | $5.80 M | -18.09% | 0.75% |
| NORTHERN TRUST CORP | 02/17/2026 | 129.02 K | $5.53 M | -6.30% | 0.72% |
| ZACKS INVESTMENT MANAGEMENT | 02/17/2026 | 119.09 K | $5.10 M | -7.13% | 0.66% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 116.95 K | $5.01 M | 54.95% | 0.65% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 109.74 K | $4.70 M | 93.88% | 0.61% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 108.27 K | $4.64 M | 10.63% | 0.60% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 02/11/2026 | 107.99 K | $4.63 M | 772.00% | 0.60% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 107.97 K | $4.62 M | -52.73% | 0.60% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 94.20 K | $4.03 M | 334.10% | 0.52% |
| RITHOLTZ WEALTH MANAGEMENT | 01/23/2026 | 80.59 K | $3.45 M | 961.27% | 0.45% |
| EMPIRE FINANCIAL MANAGEMENT COMPANY, LLC | 02/12/2026 | 76.45 K | $3.27 M | -14.60% | 0.42% |
| BARCLAYS PLC | 02/13/2026 | 75.36 K | $3.23 M | 47.57% | 0.42% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 73.85 K | $3.16 M | -37.41% | 0.41% |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 71.57 K | $3.07 M | -3.51% | 0.40% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 70.00 K | $3.00 M | 85.25% | 0.39% |
| FMR LLC | 02/17/2026 | 67.84 K | $2.91 M | 14.81% | 0.38% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 66.06 K | $2.09 M | -4.36% | 0.37% |
| PACER ADVISORS, INC. | 02/24/2026 | 65.50 K | $2.81 M | -15.46% | 0.36% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 64.83 K | $2.78 M | 12.50% | 0.36% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 62.00 K | $2.66 M | 1.93% | 0.34% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 61.04 K | $2.61 M | -15.01% | 0.34% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 57.00 K | $2.44 M | -7.72% | 0.32% |
| MAN GROUP PLC | 02/17/2026 | 56.69 K | $2.43 M | 148.25% | 0.31% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rigel Pharmaceuticals institutional Ownership - FAQ's
During the previous two years, 259 institutional investors and hedge funds held shares of Rigel Pharmaceuticals. The most heavily invested institutionals were:
Nuveen, LLC: 337,427
Bank of New York Mellon Corp: 99,924
BURNEY CO/: 91,683
RITHOLTZ WEALTH MANAGEMENT: 78,386
Inspire Investing, LLC: 63,891
UBS Group AG: 50,076
89.23% of Rigel Pharmaceuticals stock is owned by institutional investors.
Institutional investors have bought a total of 34.71 M shares in the last 24 months. This purchase volume represents approximately $974.26 M in transactions.